0 TSX Venture News - November 7, 2018Gen III Oil Corp. Receives a Senior Credit Facility Term Sheet from Export Development CanadaVANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) — Gen III Oil Corporation (“Gen III” or the “Company“) (TSX-V: GIII) […]Read More
0 TSX Venture News - November 7, 2018Luminex Resources Announces 4,500 Metre Drill Program For Orquideas Earn-in ProjectVANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) — Luminex Resources Corp. (TSXV: LR) (US OTC: LUMIF) (the “Company” or […]Read More
0 TSX Venture News - November 7, 2018Kane Biotech Senior Management Purchases 1.9 Million SharesWINNIPEG, Manitoba, Nov. 07, 2018 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), today announced […]Read More
0 TSX Venture News - November 7, 2018NuLegacy Expands Land Position in Cortez TrendAcquires Strategic Claims West of VIO Targets RENO, Nev., Nov. 07, 2018 (GLOBE NEWSWIRE) — NuLegacy Gold Corporation reports that […]Read More
0 TSX Venture News - November 7, 2018Imperial Mining Geophysics Confirms Westward Continuation of the Central Gold Zone Structure, Opawica Project, Northwestern QuébecMONTREAL, Nov. 07, 2018 (GLOBE NEWSWIRE) — Imperial Mining Group Ltd. (“Imperial”) (TSX VENTURE: IPG) is pleased to report on […]Read More
0 TSX Venture News - November 7, 2018Harfang Discovers more Gold-Rich Occurrences on its Serpent Project, James Bay (Québec)MONTRÉAL, Nov. 07, 2018 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (“Harfang”) (TSX-V: HAR) is pleased to report that fieldwork conducted […]Read More
0 TSX Venture News - November 7, 2018MediPharm Labs Corp. Completes Major Extraction MilestoneTORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (the “Company” or “MediPharm Labs”) is pleased to […]Read More
0 TSX Venture News - November 7, 2018Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference CallLAVAL, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST) (the “Company” or “Acasti”), […]Read More
0 TSX Venture News - November 7, 2018Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ TransplantationTORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) (“Revive” or the “Company”), […]Read More
0 TSX Venture News - November 7, 2018IntelGenx Announces Definitive Agreement with Tilray® to Form an Exclusive, Worldwide Partnership for Cannabis-Infused VersaFilm™ ProductsSAINT LAURENT, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, […]Read More